UPDF AI

Emerging Principles for the Therapeutic Exploitation of Glycosylation

M. Dalziel,M. Crispin,2 Authors,R. Dwek

2014 · DOI: 10.1126/science.1235681
Science · 420 Citations

TLDR

The current knowledge of glycans in pathogen invasion, cancer, autoimmunity, and congenital diseases is reviewed and glycan engineering will continue to deliver enhanced therapeutic glycoproteins, such as antibodies, with enhanced disease modifying properties.